Acurx Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Acurx Pharmaceuticals has a total shareholder equity of $2.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.0M and $3.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.76m |
| Equity | US$2.66m |
| Total liabilities | US$3.32m |
| Total assets | US$5.98m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3ZO's short term assets ($6.0M) exceed its short term liabilities ($3.3M).
Long Term Liabilities: 3ZO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 3ZO is debt free.
Reducing Debt: 3ZO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 3ZO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 3ZO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.6% each year